Get started

Financials · CLMT

Calumet Inc. (CLMT) financials

For the twelve months ended Sep 30, 2026, Calumet Inc. reported $5.20B of revenue and -$193.80M of net income.

Revenue, TTM
$5.20B
Revenue growth, YoY
+28.4%
Net income, TTM
-$193.80M
Net margin
-3.7%
Free cash flow, TTM
$265.10M
EPS, diluted, TTM
-$2.25
Cash
$225.20M
Total debt
$2.15B
P/S
0.67
Market cap
$3.48B
Annual revenue$4.14B
FY2022FY2025
Annual net income-$33.80M
FY2022FY2025
Annual free cash flow$56.60M
FY2022FY2025

CLMT revenue and earnings growth

CLMT revenueQ3 2026$1.68B

Quarter YoY
+56.1%
QoQ
+16.5%
FY YoY
-1.2%

CLMT revenue was $1.68B in fiscal Q3 2026 (ended Sep 30, 2026), up 56.1% from a year earlier and up 16.5% from the prior quarter. For the full fiscal 2025 it was $4.14B, down 1.2% from fiscal 2024. It rose in 1 of the last 3 fiscal years.

CLMT net incomeQ3 2026$256.40M

Quarter YoY
-18.2%

CLMT net income was $256.40M in fiscal Q3 2026 (ended Sep 30, 2026), down 18.2% from a year earlier. For the full fiscal 2025 it was -$33.80M, compared with -$222.00M in fiscal 2024.

CLMT EPSQ3 2026$2.91

Quarter YoY
-19.4%

CLMT diluted EPS was $2.91 in fiscal Q3 2026 (ended Sep 30, 2026), down 19.4% from a year earlier. For the full fiscal 2025 it was -$0.39, compared with -$2.67 in fiscal 2024.

CLMT free cash flowQ3 2026$206.70M

QoQ
+282.8%

CLMT free cash flow was $206.70M in fiscal Q3 2026 (ended Sep 30, 2026), compared with $0 a year earlier and up 282.8% from the prior quarter. For the full fiscal 2025 it was $56.60M, compared with -$123.10M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Revenue$4.14B$4.19B$4.18B$4.69B
Cost of revenue$3.89B$3.96B$3.73B$4.33B
Gross profit$245.70M$230.80M$451.70M$351.70M
Selling, general and admin$123.80M$145.50M$133.00M$143.40M
Operating income$108.70M$8.10M$267.20M$131.90M
Interest expense$215.80M$236.70M$221.70M$175.90M
Pre-tax income-$126.40M-$221.20M$49.70M-$169.90M
Income tax-$92.60M$800.0K$1.60M$3.40M
Net income-$33.80M-$222.00M$48.10M-$173.30M
EPS, basic-$0.39-$2.67--
EPS, diluted-$0.39-$2.67--
Diluted shares86.8M83.1M80.1M79.3M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Cash and equivalents$125.10M$45.90M$7.90M$35.20M
Receivables$232.50M$278.10M$286.20M-
Inventory$385.20M$416.30M$439.40M-
Current assets$857.80M$766.00M$794.70M-
Goodwill$140.50M$173.00M$173.00M$173.00M
Total assets$2.69B$2.76B$2.75B-
Current liabilities$840.70M$863.60M$1.11B-
Long-term debt$2.08B$2.06B$1.83B-
Total debt$2.08B$2.06B$1.83B-
Total liabilities$3.18B$3.22B$3.00B-
Shareholders' equity-$732.70M-$711.90M-$490.30M-$533.30M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Operating cash flow$108.90M-$46.40M-$14.90M$100.60M
Capital expenditures$52.30M$76.70M$271.80M$536.20M
Free cash flow$56.60M-$123.10M-$286.70M-$435.60M
Investing cash flow$44.10M-$76.70M-$271.80M-$536.00M
Financing cash flow$6.20M$154.30M$266.20M$348.70M
Stock-based compensation-$4.50M$14.60M$14.70M$17.30M
Depreciation and amortization$148.80M$149.00M$146.80M$98.30M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Revenue growth, YoY-1.2%0.2%-10.8%-
Gross margin5.9%5.5%10.8%7.5%
Operating margin2.6%0.2%6.4%2.8%
Net margin-0.8%-5.3%1.2%-3.7%
Free cash flow margin1.4%-2.9%-6.9%-9.3%
Return on assets-1.3%-8.0%1.7%-
Current ratio1.020.890.71-

Source: XBRL data Calumet Inc. files with the SEC, latest filing dated Nov 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CLMT peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
CLMT$5.20B+28.4%-$193.80M-3.7%$3.48B
XOM$396.63B+19.0%$40.62B10.2%$676.62B
CVX$233.33B+20.0%$26.98B11.6%$420.07B
COP$67.75B+13.3%$11.56B17.1%$163.71B
BP$192.55B-1.1%$55.00M0.0%$116.56B
EQNR$106.46B+2.6%$5.04B4.7%$104.97B
MPC$174.80B+31.2%$14.63B8.4%$101.49B
VLO$153.33B+24.6%$12.95B8.4%$96.62B
PSX$168.19B+27.5%$12.58B7.5%$95.85B

CLMT FAQ

9 questions
  • What is CLMT revenue?
    Calumet Inc. (CLMT) reported $5.20B of revenue for the twelve months ended Sep 30, 2026. That is up 28.4% from the year before. Revenue for fiscal 2025 was $4.14B.
  • Is CLMT profitable?
    No. Calumet Inc. reported a net loss of $193.80M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does CLMT have?
    Calumet Inc. reported $225.20M in cash and cash equivalents and $2.15B of debt on its most recent balance sheet in SEC filings.
  • How fast is CLMT revenue growing?
    Calumet Inc.'s revenue changed -1.2% in fiscal 2025, to $4.14B.
  • What is CLMT gross margin?
    Calumet Inc.'s gross profit was $471.00M on $5.20B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 9.1%.
  • What is CLMT free cash flow?
    Calumet Inc. generated $265.10M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $341.10M less capital expenditures.
  • What is CLMT earnings per share?
    Diluted earnings per share were -$2.25 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did CLMT last report financial results?
    The latest statements here come from Calumet Inc.'s 10-Q filed on Nov 6, 2026, covering the period ended Sep 30, 2026.
  • Where does this CLMT financial data come from?
    Quantisnow builds these statements from the structured XBRL data Calumet Inc. files with the SEC. It is provided for information only and is not investment advice.